Jarrod BrodskyAssociateSheppard, Mullin, Richter & Hampton LLPWebsitewww.sheppardmullin.comOrganization ProfileFull ProfileConnectEmail202.747.2180 Professional Biography Jarrod Brodsky is an associate in the Corporate Practice Group in Sheppard Mullin's Washington, D.C. office. EDUCATION J.D., Georgetown University Law Center, 2020 B.A., New York University, 2014, magna cum laude ADMISSIONS District of Columbia LANGUAGES Spanish More Legal and Business Bylines From Jarrod Brodsky HHS Issues Proposed Rule to Provide Clarity on Rights of Conscience in Healthcare - (Posted On Thursday, January 26, 2023) Don’t Let Drugs Bring You Down: The Importance of an Effective Drug Diversion Program - (Posted On Tuesday, December 06, 2022) Final Rule Changes No Surprises Act Requirements - (Posted On Thursday, September 22, 2022) Eighth Circuit: In False Claims Act Cases Based On Kickback Violations, the Kickback Violation Must Be the “But For” Cause of the Items and Services Subject to the Claim - (Posted On Friday, July 29, 2022) Supreme Court Saves Hospitals from $1.6B Cut to 340B Program - (Posted On Monday, June 20, 2022) CMS Issues Contract Year 2023 Final Rule for Medicare Advantage Organizations and Prescription Drug Sponsors - (Posted On Monday, May 16, 2022) Less is More: Brevity is the Soul of Wit - (Posted On Thursday, April 14, 2022) States Catch Health Care Entities Taking the Bait in Phishing Attacks - (Posted On Friday, February 25, 2022) Q&A: The No Surprises Act’s Protections for Uninsured (or Self-Pay) Individuals - (Posted On Thursday, February 17, 2022) CMS’ Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs - (Posted On Monday, January 10, 2022) Pagination Page 1 Next page Next › Current Legal Analysis GENIUS Act Enacted, Establishing a Regulatory Framework for Payment Stablecoins Issued or Sold in the United States by: Marina Olman-Pal , Barbara A. Jones FDA Announces Plans to Revoke 52 Standards of Identity for Food Products by: Food and Drug Law at Keller and Heckman Top Five Labor Law Developments for June 2025 by: Laura A. Pierson-Scheinberg , Richard F. Vitarelli FDA Extends Comment Period for Proposed Method for Ranking Chemicals in the Food Supply by: Food and Drug Law at Keller and Heckman FDA Calls on Infant and Children’s Food Brands to Improve Recall Communications by: Food and Drug Law at Keller and Heckman FDA Commissioner Marks His First 100 Days by: Food and Drug Law at Keller and Heckman Key Lessons: The Latest UK Office for Financial Sanctions Implementation Art Market Participants and High Value Dealers Threat Assessment by: Michael E. Ruck , Rosie Naylor President Trump Taps Two GOP Nominees for NLRB, But Uncertainty Remains by: Joshua S. Fox , Austin McLeod Cultured Salmon Company Receives “No Questions” Letter From FDA by: Food and Drug Law at Keller and Heckman Fifth Circuit Bites into NLRB: Apple’s Union Campaign Conduct Lawful by: Joshua S. Fox , Ariel N. Brotman One Big Beautiful Bill: How are North Carolina Tax-Exempt Organizations Affected? by: David P. Heeren , Steven B. Long White House Makes Key NLRB Nominations, Opening Door for NLRB to Operate at Full Capacity (US) by: Michael Fussell NYC Incorporates and Enhances NYS Paid Prenatal Leave Requirements (US) by: Scott G. Held USCIS Reaches FY 2026 H-1B Visa Cap by: Maurisa Iacono China’s National Intellectual Property Administration Releases Revised Measures for the Expedited Examination of Trademark Registration Applications by: Aaron Wininger Upcoming Events Jul 23 2025 The National Association of Women Lawyers 2025 Annual Meeting Jul 21 2025 The Big, Beautiful Webinar Series - Part One: An Introduction to the One Big Beautiful Bill Act Jul 23 2025 Navigating Emerging AI Legislation Jul 23 2025 CEQA Reform Legislation Webinar Print
